Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Epilepsy |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | October 2010 |
| Contact: | Mitch Herndon |
| Phone: | 877-352-4505 |
Open-Label Extension Study to Evaluate the Safety of USL255 as Adjunctive Therapy in Patients With Refractory Partial-Onset Seizures Who Had Participated in P09-004, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study
The purpose of this study is to examine the safety of USL255 as adjunctive therapy in
patients with refractory partial onset-seizures.
Inclusion Criteria:
- Have completed the maintenance period of the P09-004 study.
- Continue to be treated with a stable dose of 1 to a maximum of 3 approved concomitant
AEDs.
We found this trial at
11
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials